Earlier in 2019, Johnson & Johnson paid $3.4b (plus up to an additional $2.35b) for Auris Health, Inc., a maker of endoscopic robotic technologies. The Auris platform complements robotics currently in development for general surgery by Verb Surgical, a startup founded by J&J and Verily Life Sciences (an Alphabet unit), and for orthopedics by Orthotaxy, which was acquired by J&J in 2018. In Q3 2019 Siemens bought Corindus Vascular Robotics, a maker of a minimally invasive robotics for coronary, peripheral and neurovascular procedures.
With the market turning more competitive, companies are seeking to differentiate their offerings with features that make them interoperable and provide algorithmic support for complex procedure. Intuitive Surgical, Medtronic, Stryker, Smith & Nephew, Siemens and others have new robotic platforms and innovations in the pipeline.
Keywords: Healthcare Investment Banking, Healthcare M&A, Healthcare mergers